Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Organisation › Details

Tome Biosciences (Group)

Tome Biosciences, Inc., is the programmable genomic integration (PGI) company. Our technologies allow us to insert any genetic sequence of any size at any location in the genome with site-specific precision. We are writing the final chapter in genomic medicines, delivering cures to patients through cell and integrative gene therapies. *

 

Period Start 2023-12-12 start announced
Product Industry programmable genomic integration technology (PGI technology)
     
Region Region Watertown, MA
  Country United States (USA)
  Street 100 Talcott Avenue
  City 02472 Watertown, MA
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: Tome Biosciences, Inc.. (12/12/23). "Press Release: Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform". Watertown, MA.
     
   
Record changed: 2024-01-05

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Tome Biosciences (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px




» top